Showing results (21-30 of 57) with videos related to

Sort By:
Pageof 6
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 23, 2025
Brief Report: Emphysema as a Prognostic Factor in Patients With Advanced NSCLC With COPD Receiving Immune Checkpoint InhibitorsMadeleine Di Frisco, Miguel F Sanmamed, José María Ferrández, et al.
Clinical Lung Cancer|March 25, 2022
Veliparib Plus Carboplatin and Paclitaxel Versus Investigator's Choice of Standard Chemotherapy in Patients With Advanced Non-Squamous Non-Small Cell Lung CancerRamaswamy Govindan, Mike Lind, Amelia Insa, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 20, 2007
Long-term survival associated with complete resection after induction chemotherapy in stage IIIA (N2) and IIIB (T4N0-1) non small-cell lung cancer patients: the Spanish Lung Cancer Group Trial 9901Pilar Garrido, José Luis González-Larriba, Amelia Insa, et al.
Lung Cancer (Amsterdam, Netherlands)|April 20, 2025
Efficacy and safety of bintrafusp alfa evaluated in a phase II single-arm clinical trial in previously treated advanced pleural mesotheliomaErnest Nadal, Paloma Martín-Martorell, Jose Carlos Benítez, et al.
Cancer Medicine|July 23, 2021
LungBEAM: A prospective multicenter study to monitor stage IV NSCLC patients with EGFR mutations using BEAMing technologyPilar Garrido, Luis Paz-Ares, Margarita Majem, et al.
Clinical Lung Cancer|June 26, 2004
Effect of the methylenetetrahydrofolate reductase C677T polymorphism on patients with cisplatin/gemcitabine-treated stage IV non-small-cell lung cancerVicente Alberola, Carme Sarries, Rafael Rosell, et al.
Revista Espanola De Patologia : Publicacion Oficial De La Sociedad Espanola De Anatomia Patologica Y De La Sociedad Espanola De Citologia|July 12, 2020
ASTRIS, a large real-world study to evaluate the efficacy of osimertinib in epidermal growth factor receptor T790M mutation-positive non-small cell lung cancer patients: Clinical characteristics and genotyping methods in a Spanish cohortDavid Vicente-Baz, Alfredo Paredes, Teresa Morán, et al.
Lung Cancer (Amsterdam, Netherlands)|October 18, 2020
Combination of gefitinib and olaparib versus gefitinib alone in EGFR mutant non-small-cell lung cancer (NSCLC): A multicenter, randomized phase II study (GOAL)Rosario Garcia-Campelo, Oscar Arrieta, Bartomeu Massuti, et al.
Lung Cancer (Amsterdam, Netherlands)|August 27, 2019
Oral vinorelbine versus etoposide with cisplatin and chemo-radiation as treatment in patients with stage III non-small cell lung cancer: A randomized phase II (RENO study)Dolores Isla, Ramón De Las Peñas, Amelia Insa, et al.
Nature Medicine|May 31, 2025
Perioperative durvalumab plus chemotherapy plus new agents for resectable non-small-cell lung cancer: the platform phase 2 NeoCOAST-2 trialTina Cascone, Laura Bonanno, Florian Guisier, et al.
Pageof 6